BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kostapanos MS, Milionis HJ, Elisaf MS. Current role of statins in the treatment of essential hypertension. Expert Opin Pharmacother 2010;11:2635-50. [PMID: 20497095 DOI: 10.1517/14656566.2010.491512] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Kuang ZM, Feng SJ, Jiang L, Chen QX, Ji XY, Cheng WL, Hu HJ. Combined antihypertensive and statin therapy for the prevention of cardiovascular events in patients with hypertension without complications: protocol for a systematic review and meta-analysis. BMJ Open 2018;8:e019719. [PMID: 29858408 DOI: 10.1136/bmjopen-2017-019719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rizzo M, Montalto G, Banach M. The effects of statins on blood pressure: current knowledge and future perspectives. Arch Med Sci 2012;8:1-3. [PMID: 22457664 DOI: 10.5114/aoms.2012.27270] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
3 Siddiqi L, Joles JA, Oey PL, Blankestijn PJ. Atorvastatin reduces sympathetic activity in patients with chronic kidney disease. Journal of Hypertension 2011;29:2176-80. [DOI: 10.1097/hjh.0b013e32834ae3c7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
4 Banach M, Serban C, Aronow WS, Rysz J, Dragan S, Lerma EV, Apetrii M, Covic A. Lipid, blood pressure and kidney update 2013. Int Urol Nephrol 2014;46:947-61. [PMID: 24573394 DOI: 10.1007/s11255-014-0657-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
5 Kei A, Elisaf M, Moutzouri E, Tsiara S, Liberopoulos E. Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study. Int J Hypertens 2011;2011:830434. [PMID: 21747984 DOI: 10.4061/2011/830434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Tycinska AM, Janica J, Mroczko B, Musial WJ, Sawicki R, Sobkowicz B, Kaminski K, Lebkowska U, Szmitkowski M. Hypotensive effect of atorvastatin in hypertensive patients: the association among flow-mediated dilation, oxidative stress and endothelial dysfunction. Arch Med Sci 2011;7:955-62. [PMID: 22328877 DOI: 10.5114/aoms.2011.26606] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
7 Mose FH, Larsen T, Jensen JM, Hansen AB, Bech JN, Pedersen EB. Effect of atorvastatin on renal NO availability and tubular function in patients with stage II-III chronic kidney disease and type 2 diabetes. Scandinavian Journal of Clinical and Laboratory Investigation 2013;74:8-19. [DOI: 10.3109/00365513.2013.855942] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
8 Zhang YP, Zuo XC, Huang ZJ, Kuang ZM, Lu MG, Duan DD, Yuan H. The impact of blood pressure on kidney function in the elderly: a cross-sectional study. Kidney Blood Press Res 2013;38:205-16. [PMID: 24732208 DOI: 10.1159/000355769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
9 Xiong X, Wang P, Li X, Zhang Y, Li S. The Effects of Red Yeast Rice Dietary Supplement on Blood Pressure, Lipid Profile and C-reactive Protein in Hypertension: A Systematic Review. Critical Reviews in Food Science and Nutrition 2015. [DOI: 10.1080/10408398.2015.1018987] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]